News
05-21-2010, 04:40 AM
ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque, lead author of the abstract on the palifosfamide study entitled, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)", will present in an oral session at the American Society of Clinical Oncology (ASCO) Annual Meeting on Monday, June 7th at 2:15 pm in the Vista Room (location S 406).
More... (http://www.news-medical.net/news/20100521/ZIOPHARM-Oncology-to-present-phase-II-data-from-PICASSO-trial-for-soft-tissue-sarcoma-at-ASCO-meeting.aspx)
More... (http://www.news-medical.net/news/20100521/ZIOPHARM-Oncology-to-present-phase-II-data-from-PICASSO-trial-for-soft-tissue-sarcoma-at-ASCO-meeting.aspx)